A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study
Top Cited Papers
- 30 September 2000
- journal article
- clinical trial
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 109 (4), 267-276
- https://doi.org/10.1016/s0002-9343(00)00490-3
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Comparative calibration without a gold standardStatistics in Medicine, 1997
- Exploiting and Bypassing the Bone Remodeling Cycle to Optimize the Treatment of OsteoporosisJournal of Bone and Mineral Research, 1997
- Drug therapy for vertebral fractures in osteoporosis: Evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacyBone, 1996
- A 5‐year controlled randomized study of prevention of postmenopausal trabecular bone loss with nasal salmon calcitonin and calciumEuropean Journal of Clinical Investigation, 1994
- Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitoninJournal of Bone and Mineral Research, 1994
- Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assayJournal of Bone and Mineral Research, 1992
- Formation of neutralizing antibodies during intranasal synthetic salmon calcitonin treatment of postmenopausal osteoporosisOsteoporosis International, 1991
- NASAL CALCITONIN FOR TREATMENT OF ESTABLISHED OSTEOPOROSISClinical Endocrinology, 1989
- THE EFFECTS OF PARATHYROID HORMONE, COLCHICINE, AND CALCITONIN ON THE ULTRASTRUCTURE AND THE ACTIVITY OF OSTEOCLASTS IN ORGAN CULTUREThe Journal of cell biology, 1974
- Ultrastructural effects of calcitonin on osteoclasts in tissue cultureJournal of Ultrastructure Research, 1972